Concepedia

Publication | Open Access

A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

DOIFull Paper Access

102

Citations

17

References

2014

Year

Sven de Vos, Andres Forero‐Torres, Stephen M. Ansell, Brad S. Kahl, Bruce D. Cheson, Nancy L. Bartlett, Richard R. Furman, Jane N. Winter, Henry G. Kaplan, John M. Timmerman,
Journal of Hematology & Oncology

Abstract

ClinicalTrials.gov identifier NCT00435916.

References

YearCitations

Page 1